Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ADC THERAPEUTICS SA

(ADCT)
  Report
Delayed Nyse  -  04:00 2022-12-02 pm EST
3.620 USD   +4.02%
11/28Biocytogen Enters into Antibody Agreement with ADC Therapeutics
BU
11/28ADC Therapeutics, Biocytogen Pharmaceuticals Sign Antibody License Deal for Tumor Targets
MT
11/14Sobi to present new data at the ASH 2022 Annual Meeting
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart ADC THERAPEUTICS SA
Upcoming events on ADC THERAPEUTICS SA
12/10/22 | 04:15pm American society of hematology meeting - abstract number : 216
12/10/22 | 06:30pm American society of hematology meeting - abstract number : 1594
12/10/22 | 06:30pm American society of hematology meeting - abstract number : 1542
12/12/22 American society of hematology meeting - abstract number : 3598
12/12/22 American society of hematology meeting - abstract number : 2955
12/12/22 | 06:45pm American society of hematology meeting - abstract number : 1002
12/13/22 American society of hematology meeting - abstract number : 4192
12/13/22 American society of hematology meeting - abstract number : 4584
12/13/22 American society of hematology meeting - abstract number : 4297
03/16/23 FY 2022 Earnings Release (Projected)
Past events on ADC THERAPEUTICS SA
11/15/22 | 04:45am Jefferies London Healthcare Conference
11/08/22 | 08:30am Q3 2022 Earnings Call
11/08/22 | 07:00am Q3 2022 Earnings Release
09/30/22 | 06:48pm Society of Hematologic Oncology Meeting
09/28/22 | 06:05pm Society of hematologic oncology meeting - poster number : abcl-334
09/28/22 | 06:05pm Society of hematologic oncology meeting - poster number: hl-339
09/28/22 | 06:05pm Society of hematologic oncology meeting - poster number : abcl-316
09/28/22 | 06:05pm Society of hematologic oncology meeting - poster number : abcl-320
09/28/22 | 06:05pm Society of hematologic oncology meeting - poster number : abcl-272
09/13/22 | 11:45am Morgan Stanley Global Healthcare Conference - Fireside Chat
Past dividends on ADC THERAPEUTICS SA

- No events available -

Annual results
Fiscal Period : December2019202020212022
Sales
M $
Released
Forecast
Spread
2,34

 

1,03
 
33,9
33,0
2,8%
 
196
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-179
-199
9,9%
-199
-245
19%
 
-119
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-219
-197
-12%
-262
-258
-1,3%
 
-137
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-246
-241
-2,2%
-252
-263
4,4%
 
-161
 
Net income
M $
Released
Forecast
Spread


 
-246
-243
-1,3%
-230
-264
13%
 
-159
 
EPS
$
Released
Forecast
Spread
-2,36

 
-3,77
-3,53
-6,9%
-3,00
-3,36
11%
 
-2,03
 
Announcement Date04/24/202003/18/202103/03/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
13,1
7,39
78%
17,0
16,5
3,3%
46,5
37,1
25%
17,3
31,2
-45%
76,3
47,0
62%
 
27,8
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-57,1
-69,2
17%
-15,5
-77,1
80%


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-57,8
-71,7
19%
-62,8
-64,1
2,0%
-40,4
-48,2
16%
-69,4
-60,2
-15%
-3,11
-43,3
93%
 
-56,8
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-71,4
-73,8
3,2%
-56,4
-60,8
7,3%
-17,8
-52,7
66%
-65,3
-72,6
10%
-51,3
-52,5
2,3%
 
-25,8
 
Net income
M $
Released
Forecast
Spread
-71,5
-73,8
3,1%
-34,4
-64,6
47%
-16,7
-49,0
66%
-64,4
-62,3
-3,3%
-50,6
-44,7
-13%
 
-25,3
 
EPS
$
Released
Forecast
Spread
-0,93
-0,92
-1,4%
-0,45
-0,85
47%
-0,22
-0,67
67%
-0,84
-0,81
-4,2%
-0,65
-0,57
-14%
 
-0,31
 
Announcement Date11/02/202103/03/202205/09/202208/09/202211/08/2022-
Previous year Next Year
Upcoming sector events for ADC THERAPEUTICS SA
More events
Past sector events for ADC THERAPEUTICS SA
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise